Nephrostat

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNephrostat
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCollagenase inhibitors
TargetsCollagenase
Therapy Area/IndicationsDiabetes ComplicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCollagenex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCollagenex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A